{'output': [['Oxford Immunotec Global PLC', 'ORG', 'Announce', 'Company expects revenue', 'ECON_INDICATOR'], ['Company', 'ORG', 'Operate_In', 'United States', 'GPE'], ['Company', 'ORG', 'Operate_In', 'Europe', 'GPE'], ['Company', 'ORG', 'Operate_In', 'Japan', 'GPE'], ['Company', 'ORG', 'Operate_In', 'China', 'GPE'], ['Company', 'ORG', 'Introduce', 'T-SPOT ® . TB test', 'PRODUCT'], ['Company', 'ORG', 'Introduce', 'range of assays for tick-borne diseases', 'PRODUCT'], ['Company', 'ORG', 'Introduce', 'screening for Babesia in donated blood', 'PRODUCT'], ['Company', 'ORG', 'Introduce', 'focused on the transplantation market', 'SECTOR'], ['Company', 'ORG', 'Control', 'T-SPOT and the Oxford Immunotec logo', 'PRODUCT'], ['Company', 'ORG', 'Control', 'Immunetics', 'ORG'], ['Company', 'ORG', 'Raise', 'financial and operating results for the fourth quarter and full year 2017', 'ECON_INDICATOR'], ['Company', 'ORG', 'Raise', '2018 financial guidance', 'ECON_INDICATOR'], ['Company', 'ORG', 'Participates_In', '36th Annual J.P. Morgan Healthcare Conference', 'EVENT'], ['Company', 'ORG', 'Relate_To', 'preliminary unaudited financial data', 'ECON_INDICATOR'], ['Company', 'ORG', 'Relate_To', 'Company’s audit and other financial and accounting procedures', 'ECON_INDICATOR'], ['Company', 'ORG', 'Relate_To', 'previously communicated revenue outlook', 'ECON_INDICATOR'], ['Company', 'ORG', 'Relate_To', 'webcast replay', 'PRODUCT'], ['Company', 'ORG', 'Relate_To', 'investor relations page of the Company’s corporate website', 'PRODUCT'], ['Company', 'ORG', 'Relate_To', 'T-SPOT ® . TB test has been approved for sale in over 50 countries', 'ECON_INDICATOR'], ['Company', 'ORG', 'Relate_To', 'Company is currently seeking FDA licensure', 'ECON_INDICATOR'], ['Company', 'ORG', 'Relate_To', 'risks and uncertainties', 'CONCEPT'], ['Company', 'ORG', 'Relate_To', 'filings with the Securities and Exchange Commission ("SEC")', 'ORG'], ['Company', 'ORG', 'Relate_To', 'Karen Koski.Head of Strategy and Investor Relations', 'PERSON']]}